The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Director of the Nursing Research Institute
Australian Catholic University & St Vincent’s Health Australia, Sydney

Professor Sandy Middleton is Director of the Nursing Research Institute (NRI) at Australian Catholic University and St Vincent’s Health Australia. She has established the NRI as one of Australia’s largest and most productive nursing research collaboratives. Relative to opportunity (0.5 FTE academic appointment) Professor Middleton’s productivity is high: 124 peer-reviewed manuscripts in high quality journals arising from 78 research grants (>$33.3M). She led the landmark QASC trial demonstrating implementation of protocols to manage fever, hyperglycaemia and swallowing post-stroke decreased death and dependency by 16%, influencing policy and practice in Australia and being translated into 300 hospitals in 12 European countries.

Director, Infectious Diseases Department
Peter MacCallum Cancer Centre

Professor Monica Slavin is Director of the Department of Infectious Diseases at Peter MacCallum Cancer Centre and a Centre of Research Excellence in Infections in cancer. She is an international leader in the specialised field of infections in patients whose immune systems are compromised. Whilst involved in direct patient care, she has built a research group fostering multidisciplinary collaboration and health services research. She is renowned for her mentorship of a new generation of independent clinician researchers. She has held long term national leadership roles through the Australasian Society for Infectious Diseases, published 248 original research articles (cited over 8,000 times), attracted >$10 million dollars in research funding, is editor of six scientific journals and has supervised 12 PhD students.

Professor of Medical Statistics
The George Institute for Global Health

Professor Mark Woodward is one of the world’s most widely published and highly-cited biostatistician/epidemiologists. He has played a leadership role in many landmark research projects in related fields, including sex/gender differences in non-communicable diseases; epidemiology of cardiovascular diseases in Asia; vascular risk scores; prevention of complications of diabetes; causes and outcomes of renal disease; and the design and analysis of clinical trials. All of these have involved producing innovative methodology and, in each area, the outputs have led to changes in major international clinical guidelines.

Co-Program Director, Maternal and Child Health; Chair, Council of the National Health and Medical Research Council (NHMRC)
Burnet Institute

Professor Caroline Homer AO is a leading midwifery researcher in Australia with an international reputation as a leader in maternal and newborn health care and service delivery. She obtained her PhD in 2001 and since then has led research and development projects in Australia and internationally; especially in relation to health services delivery, reproductive, maternal and newborn care, human resources for health workforce development and midwifery education. She has more than 25 years of experience in the sector – as a clinician, educator, researcher and leader. Her contributions to the midwifery continuity of care model have become practice across Australia today.

Howard M. Temin Professor and Chair of Oncology; Director, McArdle Laboratory for Cancer Research
University of Wisconsin-Madison
Corresponding Fellow

Professor Paul Lambert is internationally recognised for contributions to understanding the role of papillomavirus oncogenes in cancer including the roles of the papillomavirus oncogenes E5, E6 and E7 and the role of estrogen and its receptor in cervical carcinogenesis. His current work is focussed on applying this knowledge to develop novel therapies.

Professor Lambert has collaborated with and provided materials and reagents to many research groups within Australia for over 20 years, and additionally has played a significant role in evaluation of Australian research funding proposals over the last 3 years through the Australian Cancer Research Foundation.

NHMRC Leadership Fellow; Professor of Predictive Medicine and Acting Director, Centre for Health Technologies
University of Technology Sydney

Professor Nguyen is highly recognised nationally and internationally as a leader in the field of osteoporosis research. Among much pioneering and influential work (>25,000 citations, H index 76), his development of assessment tools for identifying people at high-risk of fracture has helped millions of people worldwide. As a principal investigator of the Dubbo Osteoporosis Epidemiology Study and the newly created Vietnam Osteoporosis Study, he has contributed scientific evidence for health care policy and clinical guidelines concerning the prevention and treatment of osteoporosis internationally. His outstanding contributions and intellectual leadership are evidenced by prestigious research fellowships, awards, honorary professorships, and fellowship of the American Society for Bone and Mineral Research.

Director, Centre for Advanced Imaging
The University of Queensland

Professor David Reutens has established an international reputation for excellence in research in imaging and neuroscience and has mentored 70 PhD students and clinical and post-doctoral fellows. He is the inaugural Director of the Centre for Advanced Imaging at The University of Queensland, and has played a significant role in the development of facilities for state-of-the-art imaging research infrastructure in Australia through the National Imaging Facility. He leads the largest integrated multimodal world-class preclinical, translational and human imaging research facility in Australia, guiding its strategic development, its strong research program and research training through an ARC Industrial Transformation Training Centre.

Professor of Medicine
The University of Western Australia

Professor Timothy Davis has made many key contributions to the clinical management of diabetes and malaria. He runs the Fremantle Diabetes Study which has provided unique epidemiological insights into diabetes management and complications, has contributed to transformative diabetes intervention trials, and has been actively involved in formulating local and national treatment policies and guidelines. His malaria research in Oceania, Asia and Africa has generated pharmacokinetic and outcome data that have influenced malaria treatment guidelines in children and pregnant women. He has mentored many clinicians and researchers, and has assisted with capacity building in the tropical countries in which he has worked.

Professorial Fellow
The Royal Melbourne Hospital

Professor Bruce Campbell is an internationally recognised stroke neurologist whose research into brain imaging and emergency treatment of stroke has led to global changes in clinical practice, particularly through the widespread use of CT-perfusion imaging and endovascular thrombectomy for ischaemic stroke. He led the EXTEND-IA trial of endovascular thrombectomy (NEJM 2015, >1780 cites) that used CT perfusion imaging thresholds developed in his PhD to identify patients most likely to benefit from restoration of blood flow and then led guidelines change and Victorian statewide implementation. The CT-perfusion imaging approach was subsequently used by others to extend the treatment window to 24 hours.

Professor Director of HIV Medicine
Monash University

Professor Jennifer Hoy was appointed the inaugural Professor Director of HIV Medicine, Department of Infectious Diseases, Alfred Hospital and Monash University in 2008. Prior to this, she established and directed the internationally recognised Infectious Diseases Clinical Research Unit (1988-2008). Prof Hoy herself is internationally recognised for her research and expertise in HIV and comorbidities. Her significant contributions to the global HIV clinical research effort (including Principal Investigator for Australia on both the SMART and START global studies) and recognition as one of Australia’s leading influential researchers in HIV Medicine, makes her well placed to join the Fellowship.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.